City Name, October 21, 2025
News Summary
Kick Cancer Inc is preparing for its third annual 5k Cancer Walk on October 25 to raise funds and awareness for cancer research. This year’s event focuses on addressing disparities in cancer treatment for marginalized communities, highlighting the impact of medical racism in healthcare. Advocates emphasize the urgent need for reform in drug testing and representation in clinical trials to ensure equitable access to effective treatments, particularly for Black women diagnosed with breast cancer.
City: [City Name]
The nonprofit organization Kick Cancer Inc is gearing up for its third annual 5k Cancer Walk event on October 25, aiming to raise awareness and funds for cancer research. This year, the event takes on added significance as advocates push for meaningful changes in the way new cancer drugs are tested, particularly addressing the disparities faced by marginalized communities in healthcare.
In light of recent discussions on medical racism impacting cancer care, personal accounts from patients like breast cancer advocate Jessica Florence highlight the critical need for reform. Florence’s journey included multiple misdiagnoses and disregard from healthcare professionals regarding her concerns over a breast lump, eventually leading to a diagnosis of Stage IIIA breast cancer after switching doctors and pursuing appropriate tests.
Research indicates that Black women are diagnosed with breast cancer more often at younger ages and at later stages compared to white women. As a result, Black women are 40% more likely to die from breast cancer, underscoring systemic disparities in healthcare and medical access. Dorraya El-Ashry, PhD, points out that access to quality cancer care encompasses various barriers beyond simply seeing a physician.
Medical racism has been shown to impact the diagnosis and treatment of Black patients significantly, often leading to higher rates of misdiagnosis and poorer outcomes. Additionally, bias in pain assessment means that Black patients may be perceived as feeling less pain than white patients, contributing to inadequate pain management and treatment.
While participating in clinical trials can be a path to treatment, concerns remain regarding historical abuses in medical research involving minority populations. The Basser Center for BRCA at the University of Pennsylvania is actively working to improve awareness and participation of Black patients in breast cancer studies, recognizing the urgent need for inclusive medical research.
A recent study from the American Cancer Society revealed an alarming lack of representation of Black women in breast cancer research, impacting the development of tailored treatments for this demographic. Florence experienced extensive treatment following her initial diagnosis, including chemotherapy and surgery, but unfortunately, her cancer metastasized into Stage IV by 2020.
Florence’s experience has emphasized the importance of representation and awareness in healthcare. She found a stark lack of relatable resources and imagery for women of color during her search for information online. This gap illustrates the broader health disparities that are coming under increased scrutiny from the medical community, revealing the necessity to address systemic racism entrenched in healthcare practices.
In related developments, the National Institute for Health and Care Excellence (NICE) is evaluating Olaparib, a new drug for ovarian cancer that shows promise in delaying disease progression. This drug is set to be accessible to women in England at earlier treatment stages, potentially improving their survival rates. Although further research is needed to assess the long-term survival benefits, advocacy for equitable access to genetic testing remains crucial for women with ovarian cancer to ensure they receive appropriate targeted treatments.
In summary, as Kick Cancer Inc prepares for their 5k event, the growing movement for enhanced cancer drug testing amidst concerns of medical racism underscores the need for systemic change in healthcare practices, ensuring all patients have equitable access to effective treatments.
FAQ
What is the purpose of the 5k Cancer Walk hosted by Kick Cancer Inc?
The 5k Cancer Walk aims to raise awareness and funds for cancer research while promoting significant changes in how new cancer drugs are tested, especially for marginalized communities.
What challenges do Black women face in breast cancer diagnosis and treatment?
Black women are diagnosed with breast cancer at younger ages and later stages compared to white women, and they are 40% more likely to die from the disease due to systemic disparities in healthcare.
What is Olaparib and what is its significance in cancer treatment?
Olaparib is a new drug for ovarian cancer that shows promise in delaying disease progression and is set to be accessible to women in England at earlier treatment stages, potentially improving survival rates.
Key Features
Feature | Description |
---|---|
Event | Third Annual 5k Cancer Walk by Kick Cancer Inc on October 25 |
Medical Racism | Impacts diagnosis and treatment of Black cancer patients |
Clinical Trials | Concerns about historical abuses, but necessary for treatment options |
Olaparib | New drug for ovarian cancer showing promise for earlier access |
Deeper Dive: News & Info About This Topic
HERE Resources
Beloved Judge Frank Caprio Passes Away at 88
Robin Anderson Advances to Semifinals in Florence Open
Laurinburg Community Mourns the Loss of Barbara Brooks Mudd
Florence Community Remembers Retired Sergeant Jason Plowden
Washington D.C. Successfully Averts Government Shutdown Just Days Before Christmas
Additional Resources
- Elle: Jessica Florence’s Journey
- Wikipedia: Medical Racism
- BBC News: Breast Cancer Awareness
- Google Search: Breast Cancer Awareness
- Inquirer: Yvonne McLean Florence
- Encyclopedia Britannica: Cancer
- OncoDaily: Cancer Insights
- Google Scholar: Cancer Treatment Disparities
- Wiley Online Library: Cancer Research
- Google News: Olaparib Drug

Author: STAFF HERE FLORENCE WRITER
The FLORENCE STAFF WRITER represents the experienced team at HEREFlorence.com, your go-to source for actionable local news and information in Florence, Florence County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as the Florence Festival of Lights, Pee Dee Pride, and agricultural expos at the Florence Center. Our coverage extends to key organizations like the Florence Regional Chamber of Commerce and the Pee Dee Area Council of Governments, plus leading businesses in healthcare and retail that power the local economy such as McLeod Health and Pee Dee Electric Cooperative. As part of the broader HERE network, including HERECharleston.com, HEREColumbia.com, HEREGreenville.com, and HEREHiltonHead.com, we provide comprehensive, credible insights into South Carolina's dynamic landscape.